产品中心Products Resources
联系我们CONTACT US
-
400 179 0116
24小时服务热线
当前位置：首页 > 产品中心(Products) > 细胞定制Cell Customization(Cell Customization) > 原代细胞(Primary Cells) > 人源血液系统(Human Blood System) > 人慢性淋巴性白血病骨髓CD19+/CD5+ B细胞，未治疗
产品描述/Products Description
Chronic Lymphoid Leukemia-PB-CD19+/CD5+ B cells are isolated from Chronic Lymphoid Leukemia bone marrow mononuclear cells using a direct immunomagnetic CD19+ Micro- Bead labeling system. Available in untreated or relapsed/refractory stages. CD5 co-expression on Bone Marrow-CD19+ B Cells can be used as a strong indicator of Chronic Lymphoid Leukemia infiltration in the bone marrow. In many untreated or lower-staged Chronic Lymphoid Leukemia cases, the co-expression level of CD5 in Bone Marrow-CD19+ cells is significantly lower than the co-expression level within peripheral blood.
For research use only
